Researchers from Tokyo Metropolitan University have studied pancreatic islet cell loss in people with no previous pancreatic problems. They identified key trends in the types of cells lost due to islet cell loss in different age groups and sexes, finding that ICL in the elderly population was largely due to insulin-producing beta cell loss.
Bristol Myers to buy RayzeBio for $4.1B as pharma piles into burgeoning radiopharma field
Bristol Myers Squibb plans to buy radiopharmaceuticals biotech RayzeBio for about $4.1 billion, it announced Tuesday, hot on the heels of announcing a $14 billion